Skip to main content
OpenTrials
Completed

NCT Number: NCT02911883

Evaluation of the Repeatability and Reproducibility of AngioVue

The purpose of this study is to assess the repeatability and reproducibility of measurements of the vascular structures and the anatomical structures of the posterior pole of the eye based on AngioVue volume scans in normal subjects, glaucoma patients, and retina patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Normal, Glaucoma & Retinal Pathology Eye Diseases Glaucoma Ocular Hypertension

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Normal
  • Age > 18.
  • No retinal pathology or glaucoma.
  • Glaucoma patient
  • Age > 18.
  • Have glaucoma.
  • Retina patient
  • Age > 18.
  • Have retina pathology.

Exclusion criteria

  • Normal
  • Unable to complete required exams.
  • Poor quality image data.
  • Glaucoma patient
  • Unable to complete required exams.
  • Poor quality image data.
  • Retinal pathology.
  • Retina patient
  • Unable to complete required exams.
  • Poor quality image data.
  • Glaucoma.

Treatment and study plan

Optical coherence tomography angiography

Device

Primary outcomes

  1. Retina vasculature

    Time frame: Day 1

Sponsors and collaborators

Lead sponsor

Optovue

Industry

Registry information

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Sep 22, 2016
Registry last updated
Jun 20, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.